Niranjan B. Pandey

Biography

 Following his undergraduate degree in biochemistry from Brandeis University, Dr. Pandey received his Ph.D. in molecular biophysics from Florida State University, and completed postdoctoral fellowships at Harvard and MIT in genetics and immunology. He spent 7 years as a senior scientist in the Cancer Therapeutics Team at Johnson & Johnson developing drugs for metastatic breast cancer. Dr. Pandey continued in the biopharmaceutical sector by joining Alba Therapeutics as the Director of Biology, a position he held for 3 years. At Alba Therapeutics he was responsible for characterizing the mechanism of action of the lead clinical candidate for celiac disease. Currently he is leading the effort to develop drugs for diseases characterized by excessive angiogenesis such as age-related macular degeneration and diabetic macular edema.

Research Interest

He spent 7 years as a senior scientist in the Cancer Therapeutics Team at Johnson & Johnson developing drugs for metastatic breast cancer, and also in the field of biochemistry,biopharmaceutical sector